Genetron Holdings Q2 EPS $(0.37) Down From $(0.13) YoY
Genetron Holdings (NASDAQ:GTH) reported quarterly losses of $(0.37) per share. This is a 184.62 percent decrease over losses of $(0.13) per share from the same period last year.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 120 companies achieved new lows for the year.
Genetron Health Receives CAP Accreditation For Its Maryland Laboratory
BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), a leading precision oncology platform company in China that specializes in
Genetron Holdings Q1 Sales $17.40M Up From $14.05M YoY
Genetron Holdings (NASDAQ:GTH) reported $17.40 million in sales this quarter. This is a 23.83 percent increase over sales of $14.05 million the same period last year.
Genetron Health Releases 10 New Research Results At 2022 American Society Of Clinical Oncology Annual Meeting
Genetron Holdings Limited ((&ldquo, Genetron Health&rdquo, or the &ldquo, Company&rdquo, , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early
Earnings Scheduled For June 2, 2022
Companies Reporting Before The Bell
• SIGNA Sports United (NYSE:SSU) is projected to report earnings for its second quarter.